MedRx Co., Ltd (TYO:4586)
Japan · Delayed Price · Currency is JPY 89.00
-10.00 (-10.10%)
Sep 18, 2025, 3:30 PM JST
MedRx Revenue
MedRx had revenue of 16.00M JPY in the quarter ending June 30, 2025, a decrease of -93.07%. This brings the company's revenue in the last twelve months to 44.00M, down -82.68% year-over-year. In the year 2024, MedRx had annual revenue of 257.00M with 786.21% growth.
Revenue (ttm)
44.00M
Revenue Growth
-82.68%
P/S Ratio
112.25
Revenue / Employee
2.00M
Employees
22
Market Cap
4.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 257.00M | 228.00M | 786.21% |
| Dec 31, 2023 | 29.00M | -30.00M | -50.85% |
| Dec 31, 2022 | 59.00M | 51.00M | 637.50% |
| Dec 31, 2021 | 8.00M | -107.00M | -93.04% |
| Dec 31, 2020 | 115.00M | -54.00M | -31.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| HOYA Corporation | 876.09B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |